InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.16%
)
US TECH 100
19,107.20
(
-1.02%
)
Dow Jones
40,358.09
(
-0.14%
)
Brent Oil
80.62
(
-0.20%
)
Bitcoin
65,892.37
(
-0.05%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

walldiver

Send PM Follow Ignore
Followers 24
Posts 1614
Boards Moderated 0
Alias Born 01/02/2003

walldiver

Re: nivasvs post# 2267

Thursday, 03/22/2007 2:53:04 PM

Thursday, March 22, 2007 2:53:04 PM

Post# of 12660
Yep...interesting that Scher gets to be a voting member while the guy with a lot of immunotherapy experience can't vote because of a conflict of interest with CEGE. It's Sanofi who could be threatened by Provenge approval--not Cell Genesys. CEGE doesn't have an approved product yet for PCa. This just goes to show how much differently bureaucrats see things than the rest of us.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up